Alltrna raises $109 million in a Series B financing to advance tRNA based therapies
CEO Michelle Werner explains the science behind how Alltrna is trying to harness transfer RNA to develop therapies for stop codon disease.
top of page
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
.png){kind=logo}
The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants
bottom of page
Comments